Noxafil Powdermix (posaconazole) For Delayed-release Oral Suspension, 300 Mg, 8 Packets Per Carton, Rx Only, Manufactured For: Merck Sharp & Doohme Llc, Rahway, Nj 07056 Usa, Manufactured By: N.v. Org
Noxafil Powdermix Recall Summary Merck Sharp & Dohme is recalling Noxafil Powdermix (posaconazole) 300 mg oral suspension powder packets nationwide because they may contain metal particulates. This is a Class I recall, the most serious classification. The affected product was distributed across all U.S. states.
- Recalling firm
- Merck Sharp & Dohme LLC
- Product
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
- Reason
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification
- Class I
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2025-12-12
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/c9f853d5-b271-41b9-91a5-3dc709580da6